Advancis Will Go It Alone On Amoxicillin Pulsys
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will file NDA for pulsatile amoxicillin formulation in late 2006/early 2007 following positive Phase III results.
You may also be interested in...
Advancis Files NDA For Pulsatile Amoxicillin
The company does not rule out the possibility of copromoting the first once-daily formulation of the antibiotic as a way of expanding its sales force if Amoxicillin Pulsys is approved.
Advancis Files NDA For Pulsatile Amoxicillin
The company does not rule out the possibility of copromoting the first once-daily formulation of the antibiotic as a way of expanding its sales force if Amoxicillin Pulsys is approved.
Advancis Targeting Pharmacies In Effort To Energize Keflex 750 Sales
In sit-downs with retail pharmacy chains, Advancis is offering price incentives and arguing that the new cephalexin strength needs to be stocked because it has no generic equivalent.